{
  "summary": {
    "totalAtRisk": 14,
    "totalValue": 2850000,
    "criticalCount": 4,
    "warningCount": 6,
    "watchCount": 4
  },
  "riskFactors": [
    {"factor": "SameDayFlip", "count": 5, "description": "Deal stage changed and reverted same day", "impact": "high"},
    {"factor": "Regression", "count": 4, "description": "Deal moved backward in pipeline", "impact": "high"},
    {"factor": "Stalled", "count": 8, "description": "No activity for 30+ days", "impact": "medium"},
    {"factor": "PriceNegotiation", "count": 3, "description": "Multiple discount requests", "impact": "medium"},
    {"factor": "ChampionLoss", "count": 2, "description": "Primary contact left company", "impact": "critical"},
    {"factor": "CompetitorMentioned", "count": 4, "description": "Competitor referenced in notes", "impact": "high"}
  ],
  "atRiskOpportunities": [
    {"id": "OPP-E01", "account": "Takeda", "dealName": "CSV Platform Extension", "value": 450000, "stage": "Negotiation", "riskLevel": "critical", "flags": ["SameDayFlip", "PriceNegotiation"], "daysSinceActivity": 18, "owner": "Lisa Fry"},
    {"id": "OPP-E02", "account": "Bausch Health", "dealName": "QMS Managed Services", "value": 380000, "stage": "Proposal", "riskLevel": "critical", "flags": ["Regression", "CompetitorMentioned"], "daysSinceActivity": 22, "owner": "Scott Pallardy"},
    {"id": "OPP-E03", "account": "Integra LifeSciences", "dealName": "Validation Staff Aug FY26", "value": 320000, "stage": "Qualification", "riskLevel": "critical", "flags": ["SameDayFlip", "ChampionLoss"], "daysSinceActivity": 12, "owner": "Avani Macwan"},
    {"id": "OPP-E04", "account": "Spectranetics", "dealName": "Cloud Assurance Renewal", "value": 185000, "stage": "Negotiation", "riskLevel": "critical", "flags": ["Regression", "Stalled"], "daysSinceActivity": 35, "owner": "Jim Macdonell"},
    {"id": "OPP-E05", "account": "J&J", "dealName": "AI Validation Pilot", "value": 275000, "stage": "Proposal", "riskLevel": "warning", "flags": ["Stalled"], "daysSinceActivity": 28, "owner": "Lisa Fry"},
    {"id": "OPP-E06", "account": "Regeneron", "dealName": "IT Quality Extension", "value": 195000, "stage": "Proposal", "riskLevel": "warning", "flags": ["PriceNegotiation", "CompetitorMentioned"], "daysSinceActivity": 20, "owner": "Scott Pallardy"},
    {"id": "OPP-E07", "account": "Abbott", "dealName": "Manufacturing QA Phase 2", "value": 225000, "stage": "Qualification", "riskLevel": "warning", "flags": ["Stalled"], "daysSinceActivity": 15, "owner": "Avani Macwan"},
    {"id": "OPP-E08", "account": "Alnylam", "dealName": "RNAi Validation Expansion", "value": 165000, "stage": "Qualification", "riskLevel": "warning", "flags": ["CompetitorMentioned"], "daysSinceActivity": 14, "owner": "Lisa Fry"},
    {"id": "OPP-E09", "account": "Formation Bio", "dealName": "AI Governance Assessment", "value": 145000, "stage": "Qualification", "riskLevel": "warning", "flags": ["Stalled", "SameDayFlip"], "daysSinceActivity": 31, "owner": "Vega Finucan"},
    {"id": "OPP-E10", "account": "Harmony Biosciences", "dealName": "Managed Services Renewal", "value": 125000, "stage": "Negotiation", "riskLevel": "warning", "flags": ["PriceNegotiation"], "daysSinceActivity": 10, "owner": "Kim Guihen"},
    {"id": "OPP-E11", "account": "Moderna", "dealName": "Gene Therapy QA Support", "value": 115000, "stage": "Proposal", "riskLevel": "watch", "flags": ["Stalled"], "daysSinceActivity": 33, "owner": "Lisa Fry"},
    {"id": "OPP-E12", "account": "Ironwood", "dealName": "CSV Extension", "value": 88000, "stage": "Qualification", "riskLevel": "watch", "flags": ["CompetitorMentioned"], "daysSinceActivity": 16, "owner": "Avani Macwan"},
    {"id": "OPP-E13", "account": "Boehringer Ingelheim", "dealName": "QMS Consulting", "value": 98000, "stage": "Proposal", "riskLevel": "watch", "flags": ["Stalled", "Regression"], "daysSinceActivity": 38, "owner": "Scott Pallardy"},
    {"id": "OPP-E14", "account": "Astellas Gene Therapies", "dealName": "Manufacturing Validation", "value": 84000, "stage": "Qualification", "riskLevel": "watch", "flags": ["SameDayFlip"], "daysSinceActivity": 25, "owner": "Jim Macdonell"}
  ],
  "actionItems": [
    {"priority": 1, "action": "Executive outreach to Takeda - CSV Extension at risk, pricing concern", "owner": "Lisa Fry", "dueDate": "2026-02-12", "status": "pending"},
    {"priority": 2, "action": "Competitive response for Bausch Health - prepare differentiation deck", "owner": "Scott Pallardy", "dueDate": "2026-02-13", "status": "pending"},
    {"priority": 3, "action": "Champion replacement meeting at Integra LifeSciences", "owner": "Avani Macwan", "dueDate": "2026-02-14", "status": "in-progress"},
    {"priority": 4, "action": "Spectranetics renewal rescue - cloud assurance value prop refresh", "owner": "Jim Macdonell", "dueDate": "2026-02-11", "status": "scheduled"},
    {"priority": 5, "action": "J&J AI pilot re-engagement - schedule exec sponsor meeting", "owner": "Lisa Fry", "dueDate": "2026-02-15", "status": "pending"},
    {"priority": 6, "action": "Regeneron competitive intel briefing - pricing justification", "owner": "Scott Pallardy", "dueDate": "2026-02-12", "status": "pending"},
    {"priority": 7, "action": "Abbott Phase 2 qualification call with delivery team", "owner": "Avani Macwan", "dueDate": "2026-02-13", "status": "pending"},
    {"priority": 8, "action": "Stalled deals weekly review cadence (East team)", "owner": "East Sales Team", "dueDate": "2026-02-10", "status": "recurring"}
  ]
}
